Jason S. Ehrlich
- Ophthalmology top 0.1%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Molecular Biology top 10%
- Cell Biology top 5%
- Immunology
- Co-authors
- David S. BoyerJ. Jill HopkinsRoman G. RubioQuan Dong NguyenSunil PatelLeonard FeinerDennis M. MarcusAmy Chen Rundle
- Topics
- Retinal Diseases and Treatments (26 papers)Retinal Imaging and Analysis (21 papers)Retinal and Optic Conditions (15 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Jason S. Ehrlich
34 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Ophthalmology 3.2k
- Radiology, Nuclear Medicine and Imaging 2.6k
- Molecular Biology 944
- Cell Biology 218
- Immunology 133
Countries citing papers authored by Jason S. Ehrlich
This map shows the geographic impact of Jason S. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason S. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason S. Ehrlich more than expected).
Fields of papers citing papers by Jason S. Ehrlich
This network shows the impact of papers produced by Jason S. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason S. Ehrlich. The network helps show where Jason S. Ehrlich may publish in the future.
Co-authorship network of co-authors of Jason S. Ehrlich
This figure shows the co-authorship network connecting the top 25 collaborators of Jason S. Ehrlich. A scholar is included among the top collaborators of Jason S. Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason S. Ehrlich. Jason S. Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO | 14 |
| 4 | Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs) | 2 |
| 5 | 104 | |
| 6 | 65 | |
| 7 | Are Improvements in Diabetic Retinopathy Severity Clinically Meaningful? Insights from Studies of Intravitreal Ranibizumab (RBZ) in Patients with Diabetic Macular Edema (DME) | 2 |
| 8 | Ranibizumab for Diabetic Macular Edema: Long-Term Open-Label Extension of the Phase III RIDE and RISE Trials | 1 |
| 9 | 29 | |
| 10 | 145 | |
| 11 | Clinically significant improvement in visual acuity and predictors of early vision gains in the RIDE and RISE Phase III trials of ranibizumab for diabetic macular edema | 1 |
| 12 | Effects of Intravitreal Ranibizumab on Diabetic Retinopathy Severity: 36 Month Data from the RISE and RIDE Phase III Trials | 1 |
| 13 | The dual PPAR-α/γ agonist aleglitazar attenuates retinopathy in streptozotocin diabetic rats | 1 |
| 14 | 11 | |
| 15 | Ranibizumab for Diabetic Macular Edemabreakdown → | 1222 |
| 16 | Ranibizumab for Diabetic Macular Edema (DME): 24-Month Efficacy and Safety Results of RISE - a Phase 3 Randomized Controlled Trial | 1 |
| 17 | 76 | |
| 18 | Classification and Regression Tree Analysis to Identify Predictive Factors for Visual Acuity Outcomes in Ranibizumab Trials | 1 |
| 19 | 39 | |
| 20 | 6 |
About Jason S. Ehrlich
Jason S. Ehrlich is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Developmental Biology, having authored 36 papers that have together received 3.9k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (26 papers), Retinal Imaging and Analysis (21 papers) and Retinal and Optic Conditions (15 papers). The work is most often cited by research in Ophthalmology (3.2k citations), Radiology, Nuclear Medicine and Imaging (2.6k citations) and Developmental Biology (47 citations). Jason S. Ehrlich has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include David S. Boyer, J. Jill Hopkins, Roman G. Rubio, Quan Dong Nguyen, Sunil Patel, Leonard Feiner, Dennis M. Marcus, Amy Chen Rundle, David M. Brown and W. James Nelson. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.